Sign up
Pharma Capital

Featured articles

VIEW ALL ARTICLES

Featured companies

Redx Pharma was formed in 2010 and is an established drug discovery and development company ba...
Zynerba’s mission is to develop next-generation transdermally-delivered cannabinoid therapeuti...
Tissue Regenix Group plc is a pioneering, international medical technology company, leading th...
Cellmid Ltd (ASX:CDY) is an Australian life sciences company with lead programs in multiple di...
Shield Therapeutics is a high potential, commercial stage specialty-pharma company. We pride o...

Global biotech Newswire

Executive video interviews

VIEW ALL VIDEOS

Big picture investment ideas in Biotech Capital

VIEW ALL

Capital Network Research

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.